Success of Immunosuppressive Treatments in Patients with Chronic Graft-Versus-Host Disease

• After stopping therapy for cGVHD, half restarted after a median of 3.4 months• After 5.6 years, 1/3 each were still on IST, alive off IST, or dead/relapsed

Source: Biology of Blood and Marrow Transplantation - November 10, 2017 Category: Hematology Authors: Stephanie J. Lee, Tam D. Nguyen, Lynn Onstad, Merav Bar, Elizabeth F. Krakow, Rachel B. Salit, Paul A. Carpenter, Morgani Rodrigues, A. Marcie Hall, Barry E. Storer, Paul J. Martin, Mary E. Flowers Source Type: research